Replies to post #13437 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

The problem with investors who think they know about science also think it's somehow superior to investment sentiment.

In other words take away the emotion of the investment until the science guy himself goes through a mental meltdown.

I've seen that pattern come and go here over the years.

I equate it to pseu·do·sci·ence.

medchem

Not giving credit where it's due: small company pulled off a big trial. That deserves credit.

Sure, they deserve credit for raising the money to conduct a 160 person clinical trial. However, you're making it sound like some incredible feat - it's not. Had they got the SK study done last summer - now that would have been a helluva feat. Ifenprodil becoming a "TOP 3" COVID-19 treatment as predicted by the CEO - that would be a helluva achievement! COVID-19 data is key here and will likely determine the rest of the year here be it massive dilution or not. I'm keeping the main thing the main thing. I'm not distracted by yet another story here waiting to unfold over the next years...

Bring on the COVID-19 Data Readout! Period

M$